Methods of tangential flow filtration and an apparatus therefore

• US 20050260672A1
• Filed: 07/21/2005
• Published: 11/24/2005
• Est. Priority Date: 02/24/2003
• Status: Abandoned Application

• Current Assignee: Gtc-Biotherapeutics Incorporated
• Original Assignee: Gtc-Biotherapeutics Incorporated
• Inventors: Laverdiere, Amy, Couto, Daniel E.
• Application Number:
  US11/191,280
• Publication Number:
  US 20050260672A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C07K 1/34 by filtration, ultrafiltration or reverse osmosis

Abstract

Processes and apparati are provided for separating molecules of interest from a mixture containing them which comprises subjecting the mixture to an improved method of tangential flow filtration (TFF). The improved TFF was used to clarify, and process various feedstreams for the removal of a molecule of interest. According to a preferred embodiment, a transgenic milk feedstream is stabilized and particulate matter such as fat, casein miscelles and bacteria are removed. The method of TFF used in the current invention utilizes optimized process parameters that include temperature, transmembrane pressure, cross-flow velocity, and milk concentration. Cleaning and storage procedures were also developed to ensure long membrane life. An aseptic filtration step was also developed to remove any bacteria remaining in a clarified transgenic milk feedstream.

Claims

1-7. -7. (canceled)

10-72. -72. (canceled)

73. A method for separating a molecular species of interest from a feedstream, comprising:

(a) filtering said feedstream by a tangential-flow filtration process through a filtration membrane having a pore size that separates said molecular species of interest from said feedstream, while maintaining flux at a level greater than 100% of transition point flux outside of the pressure-dependent region of the flux versus Transmembrane Pressure (“

TMP”

) curve, wherein transmembrane pressure is not held substantially constant along said filtration membrane pathway at a level both greater than and less than a transmembrane pressure at the flux transition point of the filtration, whereby said molecular species of interest is selectively separated from said feedstream such that said molecular species of interest retains its biological activity;

(b) filtering said feedstream by an ultrafiltration process; and

wherein said molecular species of interest are biological entities selected from the group consisting of proteins, immunoglobulins, polypeptides, peptides, glycoproteins, RNA and DNA.

8. The method of claim 73, wherein said feedstream is milk.

9. The method of claim 73, wherein said feedstream is selected from one of the following sources:

cell lysate;

blood;

urine;

lymph fluid;

ascites;

or another bodily fluid.

74. The method of claim 73, further comprising fractionating said feedstream.

75. The method of claim 73, further comprising clarifying said feedstream.

76. The method of claim 73, further comprising diafiltering said feedstream.

77. The method of claim 73, further comprising concentrating said feedstream.

78. The method of claim 73, wherein the species of interest has a molecular weight of about 1 to 1000 kDa or constitutes particles greater than 0.1 μ

m.

79. The method of claim 73, wherein said protein is a biopharmaceutical.

80. The method of claim 73, wherein the condition of said feedstream is selected from one of the following states:

a) raw;

b) diluted;

c) treated with a buffer solution;

d) chemically treated; and

e) partially evaporated.

81. The method of claim 74, wherein said fractionation step utilizes ceramic filtration membranes.

82. The method of claim 74, further comprising optimizing systematic parameters.

83. The method of claim 82, wherein said systematic parameters include temperature, feedstream flow velocity, transmembrane pressure, feedstream concentration and diafiltration volume.

84. The method of claim 83, wherein the optimal temperature range is from 15°

C. to 50°

C.

85. The method of claim 82, wherein the feedstream flow velocity is from 20 cm/sec to 200 cm/sec.

86. The method of claim 82, wherein the transition point transmembrane pressure ranges from 2 psi to 40 psi.

87. The method of claim 82, wherein the feedstream concentration is from 0.25×

to 4×

of a single selected bodily fluid.

88. The method of claim 75, wherein the feedstream concentration is from 1.0×

to 2×

of a single selected bodily fluid.

89. The method of claim 82, wherein the diafiltration volume range is from 1×

to 20×

the volume of concentrated microfiltration retentate.

90. The method of claim 82, wherein the diafiltration volume range is from 3×

to 15×

the volume of concentrated microfiltration retentate.

91. The method of claim 82, wherein the diafiltration volume range is from 5×

to 10×

the volume of concentrated microfiltration retentate.

92. The method of claim 75, wherein the diafiltration volume range is from 1×

to 20×

the volume of concentrated microfiltration retentate.

93. The method of claim 75, wherein the diafiltration volume range is from 3×

to 15×

the volume of concentrated microfiltration retentate.

94. The method of claim 75, wherein the diafiltration volume range is from 5×

to 10×

the volume of concentrated microfiltration retentate.

95. The method of claim 74, wherein ultrafiltration membranes are used for all filtering steps.

96. The method of claim 77, wherein ultrafiltration membranes are used for all filtering steps.

97. The method of claim 73, wherein said feedstream is treated with a solution selected from the group consisting of:

a) water;

b) a buffered aqueous salt solution;

c) chelating agent;

d) acid solution; and

,

e) alkali solution.

98. The method of claim 76, wherein said diafiltration utilizes ultrafiltration permeate.

99. The method of claim 76 wherein said diafiltration utilizes water.

100. The method of claim 76, wherein said diafiltration utilizes a buffered salt solution.

101. The method of claim 73, wherein the filtration membranes used are cleaned with solutions of a temperature greater than 20°

C.

102. The method of claim 73, wherein the filtration membranes used are cleaned with solutions ranging in temperature from 20°

C. to 70°

C.

103. The method of claim 73, wherein the filtration membranes used are cleaned with solutions ranging in temperature from 40°

C. to 60°

C.

104. The method of claim 73, wherein the filtration membranes used are cleaned with an acid solution.

105. The method of claim 73, wherein the filtration membranes used are cleaned with an alkali solution.

106. The method of claim 73, wherein the filtration membranes used are cleaned with a hypochlorite solution.